Name: ESC HF 2017: Current Treatment Strategies for Newly Diagnosed Heart Failure Patients and the Benefit of Prolonged WCD Wear Time
Uploaded: 2017-08-21T12:29:39+01:00
Duration: 5 min 18 s
Description: Prof Veltmann (Hannover, GER) presents evidence on the topic of current treatement strategies for newly diagnosed heart failure patients and the benefit of prolonged WCD wear time.

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

ESC HF 2017: Current Treatment Strategies for Newly Diagnosed Heart Failure Patients and the Benefit of Prolonged WCD Wear Time

Published: 21 Aug 2017

Views:
136
Likes:
0

Average (ratings)

No ratings

Your rating

Prof Veltmann (Hannover, GER) presents evidence on the topic of current treatement strategies for newly diagnosed heart failure patients and the benefit of prolonged WCD wear time.